Notice Concerning Positive Results Of Phase III Study Of Bivalent Version Of Kostaive, Self-Amplifying MRNA Vaccine Against Covid-19
19/03/2024 04:02
March 19 (Reuters) - Meiji Holdings Co Ltd 2269.T :
* MEIJI HOLDINGS CO LTD- NOTICE CONCERNING POSITIVE RESULTS
OF
PHASE III STUDY OF BIVALENT VERSION OF KOSTAIVE, SELF-AMPLIFYING
MRNA VACCINE AGAINST COVID-19
Source text for Eikon: ID:nTSos87b02
Further company coverage: 2269.T
(Reporting by Rocky Swift)
((rocky.swift@thomsonreuters.com;))